⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced malignant mesothelioma

Every month we try and update this database with for advanced malignant mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
HMPL-453 in Advanced Malignant MesotheliomaNCT04290325
Advanced Malign...
HMPL-453
18 Years - Hutchmed
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046
Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by SurgeryNCT00005636
Malignant Mesot...
cisplatin
pemetrexed diso...
18 Years - Memorial Sloan Kettering Cancer Center
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046
Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryNCT00003723
Malignant Mesot...
gemcitabine hyd...
18 Years - SWOG Cancer Research Network
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaNCT00354393
Malignant Mesot...
Cisplatin
Methotrexate
Vinorelbine dit...
Adjuvant therap...
Conventional su...
Neoadjuvant The...
3-dimensional c...
Intensity-modul...
- 75 YearsThe Cleveland Clinic
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaNCT00458913
Malignant Mesot...
bortezomib
cisplatin
18 Years - 120 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNCT01105390
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
rilotumumab
cisplatin
pemetrexed diso...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaNCT00392444
Advanced Malign...
Recurrent Malig...
sunitinib malat...
18 Years - National Cancer Institute (NCI)
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyNCT01325753
Advanced Malign...
Extensive Stage...
Lung Metastases
Recurrent Malig...
Recurrent Non-s...
Recurrent Small...
Stage IV Non-sm...
cryotherapy
quality-of-life...
18 Years - Wake Forest University Health Sciences
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by SurgeryNCT00541073
Malignant Mesot...
vitamin B12
cisplatin
pemetrexed diso...
gene expression...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
Gefitinib in Treating Patients With Malignant MesotheliomaNCT00025207
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryNCT00003723
Malignant Mesot...
gemcitabine hyd...
18 Years - SWOG Cancer Research Network
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107NCT00898547
Malignant Mesot...
immunoenzyme te...
laboratory biom...
18 Years - Alliance for Clinical Trials in Oncology
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaNCT00101283
Mesothelioma
pemetrexed diso...
gemcitabine hyd...
carboplatin
18 Years - Eastern Cooperative Oncology Group
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal CancerNCT00024271
Malignant Mesot...
recombinant int...
cisplatin
doxorubicin hyd...
gemcitabine hyd...
mitomycin C
conventional su...
hyperthermia tr...
radiation thera...
18 Years - National Cancer Institute (NCI)
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedNCT00004254
Malignant Mesot...
raltitrexed
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by SurgeryNCT00005636
Malignant Mesot...
cisplatin
pemetrexed diso...
18 Years - Memorial Sloan Kettering Cancer Center
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraNCT00019825
Esophageal Canc...
Lung Cancer
Malignant Mesot...
Metastatic Canc...
decitabine
18 Years - National Cancer Institute (NCI)
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the PleuraNCT00004920
Malignant Mesot...
cisplatin
raltitrexed
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or MesotheliomaNCT00002465
Breast Cancer
Endometrial Can...
Malignant Mesot...
megestrol aceta...
18 Years - National Cancer Institute (NCI)
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Antineoplaston Therapy in Treating Patients With Advanced MesotheliomaNCT00003508
Malignant Mesot...
Antineoplaston ...
1 Year - 120 YearsBurzynski Research Institute
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryNCT00243074
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046
Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryNCT00309946
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
18 Years - National Cancer Institute (NCI)
HMPL-453 in Advanced Malignant MesotheliomaNCT04290325
Advanced Malign...
HMPL-453
18 Years - Hutchmed
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaNCT00354393
Malignant Mesot...
Cisplatin
Methotrexate
Vinorelbine dit...
Adjuvant therap...
Conventional su...
Neoadjuvant The...
3-dimensional c...
Intensity-modul...
- 75 YearsThe Cleveland Clinic
Capecitabine in Treating Patients With Malignant MesotheliomaNCT00004183
Malignant Mesot...
capecitabine
18 Years - Alliance for Clinical Trials in Oncology
Erlotinib in Treating Patients With Malignant Mesothelioma of the LungNCT00039182
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
erlotinib hydro...
laboratory biom...
- National Cancer Institute (NCI)
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural MesotheliomaNCT00075699
Malignant Mesot...
cisplatin
mitomycin C
vincristine sul...
vinorelbine tar...
pain therapy
psychosocial as...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Advanced MesotheliomaNCT00003508
Malignant Mesot...
Antineoplaston ...
1 Year - 120 YearsBurzynski Research Institute
Pazopanib in Treating Patients With Malignant Pleural MesotheliomaNCT00459862
Advanced Malign...
Localized Malig...
Recurrent Malig...
laboratory biom...
pazopanib hydro...
18 Years - National Cancer Institute (NCI)
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
HMPL-453 in Advanced Malignant MesotheliomaNCT04290325
Advanced Malign...
HMPL-453
18 Years - Hutchmed
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryNCT00365053
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
belinostat
laboratory biom...
18 Years - National Cancer Institute (NCI)
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerNCT00028782
Advanced Malign...
Localized Malig...
Malignant Ascit...
Primary Periton...
Recurrent Malig...
etanidazole
therapeutic con...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaNCT00027703
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
gemcitabine hyd...
cisplatin
bevacizumab
placebo
laboratory biom...
18 Years - National Cancer Institute (NCI)
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaNCT00458913
Malignant Mesot...
bortezomib
cisplatin
18 Years - 120 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraNCT00019825
Esophageal Canc...
Lung Cancer
Malignant Mesot...
Metastatic Canc...
decitabine
18 Years - National Cancer Institute (NCI)
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionNCT00030498
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Ependymob...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Primary H...
Adult Subependy...
Advanced Adult ...
Advanced Malign...
Male Breast Can...
Recurrent Adeno...
Recurrent Adult...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Bladd...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Malig...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage II Esopha...
Stage II Pancre...
Stage III Esoph...
Stage III Pancr...
Stage IIIB Non-...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Bladde...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Unspecified Adu...
Untreated Metas...
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsNCT00066404
Cancer
recombinant ade...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedNCT00004254
Malignant Mesot...
raltitrexed
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaNCT00392444
Advanced Malign...
Recurrent Malig...
sunitinib malat...
18 Years - National Cancer Institute (NCI)
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryNCT00309946
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
18 Years - National Cancer Institute (NCI)
PV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerNCT00055705
Cancer
PV701
18 Years - National Cancer Institute (NCI)
Alanosine in Treating Patients With CancerNCT00062283
Lung Cancer
Malignant Mesot...
Pancreatic Canc...
Sarcoma
L-alanosine
13 Years - National Cancer Institute (NCI)
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsNCT00066404
Cancer
recombinant ade...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaNCT00030459
Malignant Mesot...
cisplatin
mitomycin C
vinblastine sul...
vinorelbine tar...
- National Cancer Institute (NCI)
Pazopanib in Treating Patients With Malignant Pleural MesotheliomaNCT00459862
Advanced Malign...
Localized Malig...
Recurrent Malig...
laboratory biom...
pazopanib hydro...
18 Years - National Cancer Institute (NCI)
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNCT01105390
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
rilotumumab
cisplatin
pemetrexed diso...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: